NCT06748378

Brief Summary

Sixty-six stroke patients were randomly assigned to three groups (conventional, with the addition of the Erigo®Pro table, and enriched with motor imagery). The Trunk Stability Test, walking speed, step symmetry, and lower limb load symmetry on the Riablo device, as well as the superficial tension of the transverse abdominis and multifidus muscles, were assessed before and after completing therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2024

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

December 16, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 27, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2025

Completed
Last Updated

February 5, 2026

Status Verified

December 1, 2024

Enrollment Period

8 months

First QC Date

December 16, 2024

Last Update Submit

February 3, 2026

Conditions

Keywords

gait analysisErigo Promotor imagerystroke

Outcome Measures

Primary Outcomes (1)

  • Trunk Control Test

    Assessment of trunk stability before and after therapy

    two weeks

Secondary Outcomes (2)

  • RiabloTM device

    two weeks

  • Luna EMG

    two weeks

Study Arms (3)

Conventional rehabilitation

EXPERIMENTAL

In conventional rehabilitation, patients performed daily physiotherapy, which included intensive preparatory training for standing and sitting positions, strengthening exercises, weight-bearing exercises, and balance and coordination exercises (from 40 to 60 minutes of therapy). Interventions: Procedure: Conventional rehabilitation, the Erigo®Pro table, motor imagery

Procedure: Conventional rehabilitation, the Erigo®Pro table, motor imagery on gait.Procedure: Conventional rehabilitation, the Erigo®Pro table, motor imagery on gait parameters.

Erigo®Pro

EXPERIMENTAL

Interventions: Effective therapy included 1 session on a tilting table at an angle of 42° for 20 minutes, 5 times a week (Monday to Friday) at a speed of 32 steps per minute, followed by a physiotherapy session for two weeks. Interventions: Procedure: Conventional rehabilitation, the Erigo®Pro table, motor imagery

Procedure: Conventional rehabilitation, the Erigo®Pro table, motor imagery on gait.Procedure: Conventional rehabilitation, the Erigo®Pro table, motor imagery on gait parameters.

motor imagery (MI)

EXPERIMENTAL

in addition to conventional physiotherapy, activity imagery during passive walking on the Erigo®Pro table was introduced. During the exercises on the table, the patients wore headphones that blocked out any external sounds, closed their eyes and their task was to imagine the sensation of their body moving (first-person imagination), differentiating the idea of walking in various real environments (park, forest, beach, snow, streets). in the city, walking at different speeds, going up and down stairs, running, etc.). Interventions: Procedure: Conventional rehabilitation, the Erigo®Pro table, motor imagery

Procedure: Conventional rehabilitation, the Erigo®Pro table, motor imagery on gait.Procedure: Conventional rehabilitation, the Erigo®Pro table, motor imagery on gait parameters.

Interventions

66 stroke patients were randomly assigned to three groups (22 people each) with different therapies (conventional, with the addition of Erigo®Pro and enriched with motor imagery). The therapy duration was two weeks. Patients underwent assessment before and after completion of therapy. The study used the Trunk Stability Test, and the Riablo device to measure gate parameters. Additionally, an evaluation of the superficial tension of the transverse abdominis and multifidus muscles was conducted.

Conventional rehabilitationErigo®Promotor imagery (MI)

66 stroke patients were randomly assigned to three groups (22 people each) with different therapies (conventional, with the addition of Erigo®Pro and enriched with motor imagery). The therapy duration was two weeks. Patients underwent assessment before and after completion of therapy. The study used the Trunk Stability Test, and the Riablo device to measure the gate parameters. Additionally, an evaluation of the superficial tension of the transverse abdominis and multifidus muscles was conducted.

Conventional rehabilitationErigo®Promotor imagery (MI)

Eligibility Criteria

Age30 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \) patients 6-8 weeks post-stroke,
  • \) aged 38-85 years, mean,
  • \) males and females,
  • \) walking with or without assistance (modified Rankin scale = 3),
  • \) with slight neurological deficits (NIHSS ≤7).

You may not qualify if:

  • \) stroke up to six weeks after the episode,
  • \) epilepsy,
  • \) no possibility to sit and stand,
  • \) persistent deficit of speech and cognitive functions, lack of attention,
  • \) visual disturbances,
  • \) depression,
  • \) high or very low blood pressure, dizziness, malaise.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Military Institute of Medicine National Research Institute

Warsaw, Masovian District, 04-141, Poland

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Allocation Randomized Interventional Model Parallel Assignment Masking Double (Participant Outcomes Assessor) Primary Purpose Treatment
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PhD; Senior Specjalist of the Rehabilitation Clinic

Study Record Dates

First Submitted

December 16, 2024

First Posted

December 27, 2024

Study Start

December 1, 2024

Primary Completion

July 15, 2025

Study Completion

August 15, 2025

Last Updated

February 5, 2026

Record last verified: 2024-12

Locations